Effexor and Infusion site warmth - a phase IV clinical study of FDA data

Summary:

Infusion site warmth is reported as a side effect among people who take Effexor (venlafaxine hydrochloride), especially for people who are female, 30-39 old, also take Lasix, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site warmth when taking Effexor. It is created by eHealthMe based on reports of 92,291 people who have side effects when taking Effexor from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,496 Effexor users. Check the latest studies of Effexor.

What is Infusion site warmth?

Infusion site warmth is found to be associated with 186 drugs and 106 conditions by eHealthMe. Check the latest studies of Infusion site warmth.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

92,291 people reported to have side effects when taking Effexor.
Among them, 14 people (0.02%) have Infusion site warmth.

Could Effexor cause Infusion site warmth?

Among these 14 people:

What is the gender of people who have Infusion site warmth when taking Effexor? *

female: 100 %
male: 0.0 %

What is the age of people who have Infusion site warmth when taking Effexor? *

What are other drugs people take besides Effexor? *

What are other side effects people have besides Infusion site warmth? *

Infusion Site Erythema (reddening of the skin at infusion site): 13 people, 92.86%
Joint Pain: 6 people, 42.86%
Fatigue (feeling of tiredness): 5 people, 35.71%
Infusion Site Swelling: 5 people, 35.71%
Nausea And Vomiting: 5 people, 35.71%
Hand Fracture: 5 people, 35.71%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 5 people, 35.71%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 35.71%
Exostosis (formation of new bone on the surface of a bone): 5 people, 35.71%
Proteus Infection (proteus can cause urinary tract infections): 4 people, 28.57%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 10 people, 71.43%
Primary Immunodeficiency Syndrome: 5 people, 35.71%
Immunodeficiency: 3 people, 21.43%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and have Infusion site warmth?

- Check whether Infusion site warmth is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effexor:

Effexor (99,496 reports)

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site warmth:

Infusion site warmth (186 drugs)

Browse all the conditions that are associated with Infusion site warmth:

Infusion site warmth (106 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.